MENU
+Compare
CADL
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$11.63
Change
-$0.58 (-4.75%)
Capitalization
517.25M

CADL Candel Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CADL with price predictions
Feb 21, 2025

CADL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CADL turned positive on February 05, 2025. Looking at past instances where CADL's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 03, 2025. You may want to consider a long position or call options on CADL as a result. In of 69 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CADL moved above its 50-day moving average on January 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CADL crossed bullishly above the 50-day moving average on February 04, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CADL advanced for three days, in of 165 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CADL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CADL broke above its upper Bollinger Band on February 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CADL entered a downward trend on February 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CADL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (27.778) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). CADL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CADL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CADL is expected to report earnings to fall 21.05% to -30 cents per share on March 27

Candel Therapeutics CADL Stock Earnings Reports
Q4'24
Est.
$-0.30
Q4'23
Missed
by $0.20
Q3'23
Missed
by $0.10
Q2'23
Missed
by $0.03
Q1'23
Beat
by $0.05
The last earnings report on March 28 showed earnings per share of -37 cents, missing the estimate of -18 cents. With 1.62M shares outstanding, the current market capitalization sits at 517.25M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
42
Web
https://www.candeltx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEMTX17.57-0.05
-0.28%
Hartford Schroders Emerging Mkts Eq SDR
MDVZX8.49-0.11
-1.28%
Manning & Napier Disciplined Value Z
RSEFX14.58-0.25
-1.69%
Royce Small-Cap Special Equity Svc
GRMRX27.75-0.48
-1.70%
Nationwide S&P 500 Index R
RYLSX86.54-1.76
-1.99%
Rydex Leisure A

CADL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-4.75%
CYYNF - CADL
46%
Loosely correlated
N/A
MDGL - CADL
33%
Poorly correlated
-4.22%
NKTR - CADL
31%
Poorly correlated
-2.58%
KRRO - CADL
31%
Poorly correlated
-8.24%
DSGN - CADL
27%
Poorly correlated
-2.00%
More